Recent

% | $
Quotes you view appear here for quick access.

Endocyte, Inc. (ECYT) Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    lowest volume for a year

    by ilyak98 Apr 24, 2015 2:19 PM

    You and I could probably agree that probability favors $40 due to; 1456 and 1169 data to date. TARGET OS data to date, and the fact that PROCEED was halted due to an usually high median PFS in the control group causing "unusual" control results. Erase a trial that had unusually high control results for an unknown reason and what negatives does this company have? None. The positive column far outweighs the negative.

    Sentiment: Strong Buy

  • Reply to

    lowest volume for a year

    by ilyak98 Apr 24, 2015 2:19 PM

    It has already been proven by some analysts in the investment community that they don't really do their homework on the companies they are covering. Brean Capital has contradicted its own historical valuations, and I have heard some ask questions during conference calls that I know the answer to just based information easily obtainable on the ECYT website in the form of recorded calls or press / data releases. It seems only a handful of analysts really understand what is going on with the company, or the science of the drugs being tested. Regarding volume; it is all about demand. Institutional positions have increased, just slowly as not to create a spike in demand or price. Just wait, as others have said, until the data starts to mature. When this happens the buzz will send the demand up and it will carry the price up right along with it.

    Sentiment: Strong Buy

  • Reply to

    Volume. We getting are turn?

    by stephata75 3 hours ago

    Actually a good suggestion. It will get tossed around until 1456 and 1169 data matures and they enter Phase III testing. 12-15 months. I have confirmed that this timeline is realistic.

  • Reply to

    What am I missing ...

    by uwokid2002 3 hours ago

    Not missing anything. Just some typical covering going on in the $6 - sub $6 range. Anyone looking to cover needs to do so between news events and before major catalysts on low volume days to avoid being squeezed later on with good news. Timing is not always predictable for these quick dips but the action is fairly common since ESMO '14. Majority of open interest moving forward has shifted up to a $7 strike price from the $6 it has been at since September. This is one of the stair steps we will see as short interest continues declining; small controlled moves upward in PPS. The pressure to maintain sub $6 is becoming less and less as contracts expire and data matures, causing PPS to rise in controlled movements as we get closer to catalysts. This is all being very controlled unless an unexpected news release throws a monkey wrench in the gears. If that happens the shorts get squeezed, if it doesn't happen they have the time to turn their positions around before 1456 and 1169 get out of the Phase 1 part B and into Phase III. I personally feel that final data from TARGET, good or bad, should not move PPS up or down because 145 will not be advanced. Bad data and the shorts will likely take advantage and twist the future of the company even though the outcome of 145 does not affect what is being seen with 1456 and 1169. Good data from TARGET and it provides positive sentiment on future advancing the more powerful and tolerable 1456 and 1169. Reminder that today's PPS is the result of a study being halted because of what we know now was a control group that saw a median PFS more than double from PRECEDENT to PROCEED, and historically higher than any control group in the drugs testing history. Wny? Trial definitions are what they are, and don't take into consideration unusual occurrences; but smart investors will see all of this and take advantage while everyone else sits and watches. This company has what it takes to succeed. Patients is all that is required.

    Sentiment: Strong Buy

  • Reply to

    Volume. We getting are turn?

    by stephata75 3 hours ago

    I haven't seen anything to justify the decline and subsequent rebound. I think I may stop checking news for $ECYT; put an alert when it breaks $10/share and check back in then. lol

  • News or just Broken clock moral

  • I haven't been able to track news on $ECYT lately; why the decline today? Especially to under $6/share?

    I'm seeing a sea of red in my portfolio today, not good.

    T.

  • Reply to

    smile?....off ECYT topic.

    by shesmyworld65 Feb 26, 2015 9:21 AM

    You sound like a nut job with a serious insecurity complex. And how is your marriage "by the way"? That is actually totally off topic. So you have fake profits and a fake wife. Good job, d0uch3 bag.

  • From looking at the investor relations page I do not see confirmation the call will be taking place Thursday @8:30. Any one know? Looking forward to getting some updates and the corresponding run up there after.

    Sentiment: Strong Buy

  • Reply to

    smile?....off ECYT topic.

    by shesmyworld65 Feb 26, 2015 9:21 AM

    You think you're a know it all and don't know #$%$. No I didn't sell yet, probably Monday 1/2. And I still own this. Your method, buy high and don't put no stops in. I'm still higher on this one, and you're down quite a bit. It was your smart #$%$ mouth that got this started, not me. You got a long way to get to $17+ again. What kind of trader buys @ $17+ watches it crumble? You, ya dumb#$%$. Fall in love with a girl not a stock. By the way, I'm happily married cause..shesmyworld...One as stupid and a smart #$%$ like you, only has their hand to sleep with. By the way, if you can read, I said I was going to pick AGEN up the next day if it dropped to the $4.80s and it did. What did you want me to do? Scream out yay I got in at the price I said I would the very next day!? It sounds like you are still #$%$ over your screw up on ECYT. You shouldn't have been a smart #$%$ from my question, which was more directed to smiletothebank. Glad I didn't listen to you. Bye now and happy trading.

  • Reply to

    lowest volume for a year

    by ilyak98 Apr 24, 2015 2:19 PM

    Posters never generate much interests. The company's problem is last year everybody got very badly burned and are going to be VERY slow in coming back. They are going to need a clinical with fantastic results or a major partnership

  • Reply to

    lowest volume for a year

    by ilyak98 Apr 24, 2015 2:19 PM

    Eh, just wait until they get some good published results from the studies. Stock will either go to $4 or $40 soon enough. Be patient.

    AVNR stayed around $3 for ages with no volume, but then suddenly sold for $17.

  • Stock hasthe lowest volume for a year . No institution interest . it's frustrating . None of the recent presentations moved the stock . Why so much exceitment on this board regarding their research , and it's not shared by invesmtent community ?

    Sentiment: Hold

  • only i'm the one trying to kick the football

  • Reply to

    The Posters Just Hit The ECYT Site

    by darren3129 Apr 22, 2015 1:15 PM

    unfortunately I agree with you, I expect nothing until they start to pick up some sponsorship, which they lost last year. People are always reluctant to step forward after getting burnt once

  • Reply to

    The Posters Just Hit The ECYT Site

    by darren3129 Apr 22, 2015 1:15 PM

    Posters continue showing that they have the goods.

    Sentiment: Buy

  • Reply to

    smile?....off ECYT topic.

    by shesmyworld65 Feb 26, 2015 9:21 AM

    Hahahaha! Suuuure you did! Did you keep this old conversation bookmarked? I had totally forgotten about it until I noticed the notification that I had a reply. Good job on your fake 20% profits. I, a stranger on the internet, am super impressed. Go call your mom to tell her. Or walk upstairs and tell her in person.

  • Reply to

    smile?....off ECYT topic.

    by shesmyworld65 Feb 26, 2015 9:21 AM

    While this still sits in the same range, I guess when I picked up AGEN @ $4.83 & $4.89 like I said I would, now trading over $6.00. Guess I wasn't a day late and a dollar short eh? Sold 1/2 my position for a nice profit. With the deals going on with AGEN, it has a bright future. You were in no postion to lecture me, especially when you bought ECYT at what $17.00+ Looks like it was you trying to catch a falling knife. No stops in place? You just watched your losses pile up. Glad I didn't listen to you, your trading methods are scary

  • Reply to

    The Posters Just Hit The ECYT Site

    by darren3129 Apr 22, 2015 1:15 PM

    Yeah It's good news ! But I don't think it will have major effect on the stock ! But I believe the stock will increase gradually and must hit 7 back soon

  • Reply to

    The Posters Just Hit The ECYT Site

    by darren3129 Apr 22, 2015 1:15 PM

    Antitumor efficacy of EC1456 in PDX models of Ovarian, Endometrial, NSCLC & TNBC

    "EC1456
    alone demonstrated tumor growth suppression or stasis in most of the
    tumor models and significantly greater anti-tumor activity (including
    cures) with no detectable increase in toxicity when tested in
    combination with the SOC agents. Overall, EC1456 significantly
    augmented the growth inhibitory effects of SOC treatments against all
    four PDX cancer indications examined, thus lending support to future
    clinical development of this novel FR-targeted agent."

    Sentiment: Strong Buy

ECYT
6.12+0.04(+0.66%)2:18 PMEDT